[go: up one dir, main page]

GB587992A - Improvements in and relating to the production of organic nitrogen compounds - Google Patents

Improvements in and relating to the production of organic nitrogen compounds

Info

Publication number
GB587992A
GB587992A GB24763/44A GB2476344A GB587992A GB 587992 A GB587992 A GB 587992A GB 24763/44 A GB24763/44 A GB 24763/44A GB 2476344 A GB2476344 A GB 2476344A GB 587992 A GB587992 A GB 587992A
Authority
GB
United Kingdom
Prior art keywords
nitro
compounds
solvent
water
dinitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24763/44A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB24763/44A priority Critical patent/GB587992A/en
Publication of GB587992A publication Critical patent/GB587992A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/08Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Organic nitro compounds, for example, dinitro compounds, nitro alcohols and nitro-nitrate compounds, are produced by reacting a mixture containing at least one compound selected from an aliphatic mono-olefine having at least 7 carbon atoms, or a cyclic mono-olefine having at least 5 carbon atoms or substituted derivatives of such aliphatic or cyclic mono-olefines with nitrogen tetroxide in the presence or absence of oxygen or air, and treating the reaction product with water or a lower aliphatic alcohol containing less than six carbon atoms which hydrolyses the nitrites formed in the nitration to the nitro alcohols. If desired, the nitration may be carried out in the presence of a solvent inert to the reactants. Examples of suitable mono-olefinic compounds which may be so reacted are trimethylpentenes, cyclohexene, oleic acid, cracked paraffin wax and ethyl acrylate. With some olefinic hydrocarbons and their derivatives, particularly the C7-C10 aliphatic olefines and the cyclic olefines, it is preferable to carry out the nitration in the presence of an oxygen - containing solvent selected from: saturated aliphatic, alicyclic, or aliphatic-alicyclic compounds containing carbon, hydrogen and oxygen only and having no oxygen-containing groups except ether or ester groups and no 3- or 4- membered rings, but excluding esters of formic acid; saturated heterocyclic or aliphatic - heterocyclic compounds containing carbon, hydrogen and oxygen only and having only carbon and oxygen in the ring and no other groups except hydrogen, hydrocarbon, ether or ester groups but excluding such compounds containing 3- or 4-membered rings; preferably the solvent boils below 180 DEG C. and melts below 50 DEG C. Mixtures of these solvents alone or with other inert solvents may be used but should be such as can be boiled off below 180 DEG C. Examples of some of these solvents are alkyl mono-ethers, diethers, dioxan, tetrahydrofuran, and esters of saturated aliphatic mono-carboxylic acids. With other olefinic compounds, other solvents for nitrogen tetroxide may be employed. It is preferred to operate the process in the liquid phase and at atmospheric pressures and temperatures. The oxygen may be introduced continuously or at various stages in the reaction. In working up the reaction product, water is preferred when the nitro alcohols formed are water soluble since they may then be isolated from the aqueous solution by solvent extraction; the dinitro and other nitro-compounds can then be recovered from the residual oil. Before the water or alcohol treatment, the solvent and remaining nitrogen oxides should preferably be removed from the reaction product. The dinitro compounds may also be recovered by freezing out from the reaction product before the water treatment and before or after removing solvent. Again, if a solvent boiling below 100 DEG C. is used in the main reaction, the product may be well mixed with water, the solvent distilled off under reduced pressure, the aqueous layer separated and the nitro alcohols isolated therefrom by solvent extraction, and the dinitro-compounds and nitro-nitrates recovered from the residual oil. Also, a water immiscible solvent may be used in the main reaction, the product treated with water and the aqueous layer containing nitro-alcohols separated from the solvent layer of dinitro-compounds and nitro-nitrates from which the nitro-compounds may be recovered. If the nitro-alcohols are insoluble in water, then after water-treatment the washed product may be fractionally distilled to isolate the nitro-alcohols, dinitro-compounds and nitro-nitrates. In a further modification, the nitration products are treated with methanol and the dinitro compounds isolated by freezing out from the methanol solution. In examples: (1) 2,4,4,-trimethylpentene-1 was reacted with a solution of nitrogen tetroxide in dry methylated ether at 0 DEG C., the product being freed of solvent, washed with water, dried and fractionated, yielding 2,4,4-trimethyl-1,2-dinitropentane and 2,4,4-trimethyl-1-nitro-pentanol-2. (2) Oleic acid was reacted with an ether solution of nitrogen tetroxide and the product washed with water after removal of solvent, giving a product containing dinitro-stearic acid and mono-nitro mono-hydroxy stearic acid and its nitrate ester. (3) Nitrogen tetroxide was reacted with an ethereal solution of cracked paraffin wax consisting of C15 hydrocarbons, containing 45 per cent mono-olefines, the product being stripped of solvent, water washed and the saturated hydrocarbon portion distilled off; the residue comprised a mixture of nitro-alcohol and dinitro compound. (4) Nitrogen tetroxide and cyclohexene were reacted in ether in the presence of a stream of oxygen; after removing solvent the product was waterwashed and 1-nitro-cyclohexanol-2 isolated by solvent extraction from the washings and 1,2-dinitro-cyclohexane recovered from the insoluble residue by distillation. According to the Provisional Specification, any cyclic monoolefine may be used as a starting material. Specifications 572,949 and 580,260 are referred to.
GB24763/44A 1944-12-11 1944-12-11 Improvements in and relating to the production of organic nitrogen compounds Expired GB587992A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB24763/44A GB587992A (en) 1944-12-11 1944-12-11 Improvements in and relating to the production of organic nitrogen compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24763/44A GB587992A (en) 1944-12-11 1944-12-11 Improvements in and relating to the production of organic nitrogen compounds

Publications (1)

Publication Number Publication Date
GB587992A true GB587992A (en) 1947-05-12

Family

ID=10216867

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24763/44A Expired GB587992A (en) 1944-12-11 1944-12-11 Improvements in and relating to the production of organic nitrogen compounds

Country Status (1)

Country Link
GB (1) GB587992A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2621205A (en) * 1949-08-15 1952-12-09 Union Oil Co Nitration of olefins
US6924309B2 (en) * 1999-09-17 2005-08-02 Children, Youth And Women's Health Service Incorporated Anti-inflammatory nitro and thia-fatty acids
WO2005110396A3 (en) * 2004-04-28 2007-03-01 Uab Research Foundation Nitrated lipids and methods of making and using thereof
US9585855B2 (en) 2008-06-19 2017-03-07 The University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
US9663444B2 (en) 2009-10-02 2017-05-30 Complexa, Inc. Heteroatom containing substituted fatty acids
US9700534B2 (en) 2007-08-01 2017-07-11 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US9750725B2 (en) 2009-07-31 2017-09-05 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US9790167B2 (en) 2008-05-01 2017-10-17 Complexa, Inc. Vinyl substituted fatty acids
US10010532B2 (en) 2011-08-19 2018-07-03 The University Of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
US10369125B2 (en) 2008-06-19 2019-08-06 The University Of Utah Research Foundation Method of treating renal system damage
US10537541B2 (en) 2015-10-02 2020-01-21 Complexa Inc. Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid
US11608342B2 (en) 2015-07-07 2023-03-21 H. Lundbeck A/S PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
US12006319B2 (en) 2018-05-25 2024-06-11 Cardurion Pharmaceuticals, Inc. Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one
US12213975B2 (en) 2018-08-31 2025-02-04 Cardurion Pharmaceuticals, Inc. PDE9 inhibitors for treating sickle cell disease

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2621205A (en) * 1949-08-15 1952-12-09 Union Oil Co Nitration of olefins
US6924309B2 (en) * 1999-09-17 2005-08-02 Children, Youth And Women's Health Service Incorporated Anti-inflammatory nitro and thia-fatty acids
US9867795B2 (en) 2004-04-28 2018-01-16 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
WO2005110396A3 (en) * 2004-04-28 2007-03-01 Uab Research Foundation Nitrated lipids and methods of making and using thereof
US7776916B2 (en) 2004-04-28 2010-08-17 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US8309526B2 (en) 2004-04-28 2012-11-13 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US9006473B2 (en) 2004-04-28 2015-04-14 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US9295678B2 (en) 2004-04-28 2016-03-29 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US9522156B2 (en) 2004-04-28 2016-12-20 The Uab Research Foundation Nitrated lipids and methods of making and using thereof
US9700534B2 (en) 2007-08-01 2017-07-11 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US10258589B2 (en) 2007-08-01 2019-04-16 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US10576051B2 (en) 2007-08-01 2020-03-03 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US10869850B2 (en) 2007-08-01 2020-12-22 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
US9790167B2 (en) 2008-05-01 2017-10-17 Complexa, Inc. Vinyl substituted fatty acids
US9585855B2 (en) 2008-06-19 2017-03-07 The University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
US10369125B2 (en) 2008-06-19 2019-08-06 The University Of Utah Research Foundation Method of treating renal system damage
US10568857B2 (en) 2008-06-19 2020-02-25 The University Of Utah Research Foundation Method of treating renal system damage
US10835518B2 (en) 2009-07-31 2020-11-17 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US9750725B2 (en) 2009-07-31 2017-09-05 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US10213417B2 (en) 2009-07-31 2019-02-26 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US11723897B2 (en) 2009-07-31 2023-08-15 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US9663444B2 (en) 2009-10-02 2017-05-30 Complexa, Inc. Heteroatom containing substituted fatty acids
US10010532B2 (en) 2011-08-19 2018-07-03 The University Of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
US10709690B2 (en) 2011-08-19 2020-07-14 The University Of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
US11608342B2 (en) 2015-07-07 2023-03-21 H. Lundbeck A/S PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
US10537541B2 (en) 2015-10-02 2020-01-21 Complexa Inc. Treatment of focal segmental glomerular sclerosis (FSGS) using therapeutically effective oral doses of 10-nitro-9(E)-octadec-9-enoic acid
US12006319B2 (en) 2018-05-25 2024-06-11 Cardurion Pharmaceuticals, Inc. Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one
US12213975B2 (en) 2018-08-31 2025-02-04 Cardurion Pharmaceuticals, Inc. PDE9 inhibitors for treating sickle cell disease

Similar Documents

Publication Publication Date Title
GB587992A (en) Improvements in and relating to the production of organic nitrogen compounds
US2472550A (en) Manufacture of organic nitro
US1882978A (en) Recovery of unsaturated aliphatic hydrocarbons
US2441183A (en) Hexahydrobenzyl ester
GB936400A (en) Process for the manufacture of carboxylic acid-tertiary alkyl esters
US2472086A (en) Carburetor process for acetylene reactions
US2347621A (en) Process for reduction of nitro hydroxy compounds
US3232999A (en) Separation of nitrotoluene or nitrobenzene
US2746984A (en) Process for the separation of aliphatic alchols from hydrocarbon-alcohol mixtures
US2516126A (en) Separation of organic compounds
US2780634A (en) Liquid phase oxidation of a mixture of alkanes and alkenes with air
US2495424A (en) Production of nitro olefins
GB743446A (en) Improvements in or relating to aromatic 2-aminoalkanediols-(1.3)
US2372221A (en) Process of acetylating 2,3-butylene glycol with the impure acetic acid obtained from the pyrolytic decomposition of 2,3-butylene glycol diacetate to butadiene
US2243471A (en) Manufacture of nitric acid esters
US2238195A (en) Nitration of organic compounds
US2374484A (en) Esters of nitrohydroxy compounds
US3726888A (en) Esterification and extraction process
US2384048A (en) Manufacture of organic nitrogen compounds
US3026357A (en) Preparation of hexahydroxy-cyclododecane
US3060244A (en) Preparation of glycols from dienes and diborane
US2710830A (en) Method of preparing nitro aliphatic compounds
US2491933A (en) Process for the manufacture of esters of monomethylene ethers of 1 keto-2 gulonic acid
US2755301A (en) High molecular weight nitriles derived from microcrystalline wax oxidate acids
US2044502A (en) Process for the purification of pyrethrin concentrates